Locations:
Search
While the retropubic approach is popular, is the perineal approach equally effective and less invasive?
Here’s why you should attend this two-day conference
The first approved treatment for men with nonmetastatic castration-resistant prostate cancer (M0CRPC)
6 Q&A’s with Drogo K. Montague, MD
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Tips for improving diagnostic accuracy and preventing UTIs
Positive results point to a better prognosis for intractable disease
Residential life expectancy may be a non-traditional risk factor
Uncovering the Biology of Health Disparities
Why can male fertility be reduced even before treatment begins?
Using “opportunistic imaging” to identify significant comorbidities such as cardiovascular risk and bone health
Advertisement
Advertisement